•
Mar 31, 2023

Inhibrx Biosciences Inc Q1 2023 Earnings Report

Total Revenue
$17K
Previous year: $929K
-98.2%
EPS
-$1.12
Previous year: -$0.8
+40.0%
Free Cash Flow
-$40M

Inhibrx Biosciences Inc

Inhibrx Biosciences Inc